News | Breast Density | April 06, 2017

Beginning Oct. 1, 2017, mammography facilities will be required to notify patients if they have dense fibroglandular breast tissue, warn them of increased cancer risk

Colorado, fibroglandular breast density, reporting bill, mammography, breast cancer

April 6, 2017 — Colorado Gov. John Hickenlooper signed the Dense Breast Tissue Reporting Bill (SB17-142) on April 6, adding to the growing list of density reporting laws across the country. The signing makes Colorado the 29th state to enact some form of legislation requiring mammography facilities to notify patients about the impact of fibroglandular breast density on cancer detection and risk.

The language of SB17-142 requires mammography providers to include a notification in the report provided to the patient if the patient is found to have dense fibroglandular breast tissue. The notice must also inform the patient that while common, dense breast tissue can make it more difficult to evaluate the results of the mammogram and it is associated with an increased risk of breast cancer.

The bill was introduced in the Colorado Legislature by Sen. Angela Williams and sponsored in the House by Rep. Jessie Danielson.  The Colorado Breast Density Coalition actively advocated for the law.

“This is a victory for Colorado women,” said Williams.  "Now all women in Colorado will have the same information as their doctors."  

Danielson added, "This law encourages patients to discuss with healthcare providers screening options that are personalized to a patient with dense breast tissue. It is one solution to increase the early detection of breast cancer."

The law is effective on Oct. 1, 2017.  Currently, New Mexico, Iowa and Kentucky have breast density reporting bills awaiting governors' action.

For more information on dense breast tissue, read the article "Mammographic Breast Density — What It Means."

For more information: www.areyoudense.org


Related Content

News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
Subscribe Now